Archive · 18 Sep 2025
Sagility India Receives Buy Rating with ₹60 Target
Imagine a company called Sagility India, which helps healthcare businesses.
Experts think it's a good investment.
They gave it a 'Buy' rating, meaning they believe the company's value will go up.
They predict the stock price could reach ₹60.
Sagility has lots of clients and is adding new ones, while also using AI to improve its services.
They have developed AI tools like Nurse Assist and Appeals Assist.
However, there are risks, such as depending too much on a few big clients, changes in US healthcare rules, and employee turnover.
Sagility India is a healthcare-focused BPM and digital transformation company.
The company has a 'Buy' rating with a target price of ₹60.
In Q1 FY26, Sagility onboarded 4 new clients and expanded business with 18 existing clients.
Sagility is investing heavily in AI and automation with 18 live use cases.
Key risks include high client concentration and US healthcare regulatory changes.
- Who
- Sagility India
- What
- Received a Buy rating with a target price of ₹60.
- When
- Published on September 18, 2025.
- Where
- N/A
- Why
- Due to its deep healthcare domain expertise, long-standing client relationships, rising profitability, and strategic focus on AI-led transformation.
- Company
- Sagility India
- Rating
- Buy
- Target Price
- ₹60
- Current Market Price (CMP)
- ₹46.48
- Business
- Healthcare-focused BPM and digital transformation
- Clients
- 77 active clients
- New Business in Q1 FY26
- $32 M (potential steady state ACV)